Not all anti-parietal cell antibody tests are equal for diagnosing pernicious anemia
The progression-free survival (PFS) and overall survival (OS) outcomes, which were announced in January 2026, will be shared in further detail at a future medical meeting
Retatrutide, a novel GLP-1 drug in Phase 3, has not yet been approved by the FDA, restricting access to clinical environments and ruling out regular prescriptions in most locations
It does this in a context-dependent way, responding to local tissue needs rather than ramping up growth signals everywhere
That does not mean failure
Look for "Grilled," "Baked," or "Steamed": Avoid dishes described as "fried," "crispy," "creamy," or "sauted" (which can imply a lot of oil or butter)